BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 29376051)

  • 21. A multi-centre, double-blind, randomized, placebo-controlled trial to evaluate the effectiveness and safety of ramelteon for the prevention of postoperative delirium in elderly cancer patients: a study protocol for JORTC-PON2/J-SUPPORT2103/NCCH2103.
    Sadahiro R; Hatta K; Yamaguchi T; Masanori E; Matsuda Y; Ogawa A; Iwata Y; Tokoro A; Nakahara R; Hirayama T; Yanai Y; Ogawa Y; Kayano A; Ariyoshi K; Oyamada S; Uchitomi Y; Akechi T; Yamamoto N; Okita N; Yorikane E; Shimada K; Furukawa T; Hashimoto H; Maeda M; Sato T; Sekimoto A; Sasaki C; Saito E; Uezono Y; Matsuoka H
    Jpn J Clin Oncol; 2023 Aug; 53(9):851-857. PubMed ID: 37340766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prophylactic effect of exogenous melatonin and melatonin receptor agonists on postoperative delirium in elderly patients: a systemic review and meta-analysis of randomized controlled trials.
    Jiang LS; Lai L; Chen YJ; Liu K; Shen QH
    Aging Clin Exp Res; 2023 Nov; 35(11):2323-2331. PubMed ID: 37776484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of Ramelteon in Reduction of As-Needed Antipsychotics in Elderly Patients with Delirium in a General Hospital Setting.
    Pinkhasov A; James SA; Fazzari M; Singh D; Lam S
    Clin Drug Investig; 2017 Dec; 37(12):1137-1141. PubMed ID: 28933013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Melatonin intervention to prevent delirium in hospitalized patients: A meta-analysis.
    You W; Fan XY; Lei C; Nie CC; Chen Y; Wang XL
    World J Clin Cases; 2022 Apr; 10(12):3773-3786. PubMed ID: 35647160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preventive effects of ramelteon on delirium: a randomized placebo-controlled trial.
    Hatta K; Kishi Y; Wada K; Takeuchi T; Odawara T; Usui C; Nakamura H;
    JAMA Psychiatry; 2014 Apr; 71(4):397-403. PubMed ID: 24554232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of melatonin on delirium in hospitalised patients: A systematic review and meta-analyses with trial sequential analysis.
    Ng KT; Teoh WY; Khor AJ
    J Clin Anesth; 2020 Feb; 59():74-81. PubMed ID: 31279283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative efficacy and acceptability of pharmacological interventions for the treatment and prevention of delirium: A systematic review and network meta-analysis.
    Kim MS; Rhim HC; Park A; Kim H; Han KM; Patkar AA; Pae CU; Han C
    J Psychiatr Res; 2020 Jun; 125():164-176. PubMed ID: 32302794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ramelteon is Not Associated With Improved Outcomes Among Critically Ill Delirious Patients: A Single-Center Retrospective Cohort Study.
    Thom R; Bui M; Rosner B; Teslyar P; Levy-Carrick N; Wolfe D; Klompas M
    Psychosomatics; 2019; 60(3):289-297. PubMed ID: 30193784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ramelteon for the treatment of insomnia.
    Borja NL; Daniel KL
    Clin Ther; 2006 Oct; 28(10):1540-55. PubMed ID: 17157111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Melatonin and melatonin-receptor agonists to prevent delirium in hospitalized older adults: An umbrella review.
    Blodgett TJ; Blodgett NP
    Geriatr Nurs; 2021; 42(6):1562-1568. PubMed ID: 34749057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Melatonin receptor agonists-ramelteon and melatonin-for bipolar disorder: a systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials.
    Kishi T; Nomura I; Sakuma K; Kitajima T; Mishima K; Iwata N
    Neuropsychiatr Dis Treat; 2019; 15():1479-1486. PubMed ID: 31239683
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of Administration of Ramelteon, a Melatonin Receptor Agonist, on the Duration of Stay in the ICU: A Single-Center Randomized Placebo-Controlled Trial.
    Nishikimi M; Numaguchi A; Takahashi K; Miyagawa Y; Matsui K; Higashi M; Makishi G; Matsui S; Matsuda N
    Crit Care Med; 2018 Jul; 46(7):1099-1105. PubMed ID: 29595562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endogenous Melatonin Levels and Therapeutic Use of Exogenous Melatonin in Migraine: Systematic Review and Meta-Analysis.
    Liampas I; Siokas V; Brotis A; Vikelis M; Dardiotis E
    Headache; 2020 Jul; 60(7):1273-1299. PubMed ID: 32352572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-pharmacological interventions for sleep promotion in the intensive care unit.
    Hu RF; Jiang XY; Chen J; Zeng Z; Chen XY; Li Y; Huining X; Evans DJ
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD008808. PubMed ID: 26439374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emerging Role of Melatonin and Melatonin Receptor Agonists in Sleep and Delirium in Intensive Care Unit Patients.
    Mo Y; Scheer CE; Abdallah GT
    J Intensive Care Med; 2016 Aug; 31(7):451-5. PubMed ID: 26092575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Melatonin and melatonin agonists to prevent and treat delirium in critical illness: a systematic review protocol.
    Foster J; Burry LD; Thabane L; Choong K; Menon K; Duffett M; Cheung A; Guenette M; Chimunda T; Rose L
    Syst Rev; 2016 Nov; 5(1):199. PubMed ID: 27881185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preventative effects of ramelteon against postoperative delirium after elective liver resection.
    Hokuto D; Nomi T; Yoshikawa T; Matsuo Y; Kamitani N; Sho M
    PLoS One; 2020; 15(11):e0241673. PubMed ID: 33137161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prophylactic use of exogenous melatonin and melatonin receptor agonists to improve sleep and delirium in the intensive care units: a systematic review and meta-analysis of randomized controlled trials.
    Zhang Q; Gao F; Zhang S; Sun W; Li Z
    Sleep Breath; 2019 Dec; 23(4):1059-1070. PubMed ID: 31119597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and moderators of prevention and treatment of delirium with melatonin receptor agonists: A systematic review and meta-analysis of randomized controlled trials.
    Wada M; Yasuda H; Nakajima S; Etani T; Miura A; Asada S; Yoshida K; Noda Y; Takeuchi H
    Gen Hosp Psychiatry; 2023; 85():71-79. PubMed ID: 37826886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.